Bacteriocins of Lactic Acid Bacteria -

Bacteriocins of Lactic Acid Bacteria (eBook)

eBook Download: PDF | EPUB
2014 | 1. Auflage
298 Seiten
Elsevier Science (Verlag)
978-1-4832-7367-9 (ISBN)
Systemvoraussetzungen
Systemvoraussetzungen
54,95 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Bacteriocins of Lactic Acid Bacteria
Bacteriocins of Lactic Acid Bacteria is based on the 1990 Annual Meeting of the Institute of Food Technologists held in Dallas, Texas. It describes a number of well-characterized bacteriocins and, where possible, discusses practical applications for those that have been defined thus far from the lactic acid bacteria. The book begins with an introductory overview of naturally occurring antibacterial compounds. This is followed by discussions of methods of detecting bacteriocins and biochemical procedures for extraction and purification; genetics and cellular regulation of bacteriocins; bacteriocins based on the genera of lactic acid bacteria Lactococcus, Lactobacillus, Pediococcus, and Leuconostoc, and related bacteria such as Carnobacterium and Propionibacterium; and the regulatory and political aspects for commercial use of these substances. The final chapter sets out the prognosis for the future of this dynamic area. The information contained in this book should benefit those with interest in the potential for industrial use of bacteriocins as preservative ingredients. Anyone interested in lactic acid bacteria or the biosynthesis, regulation, and mechanisms of inhibition of these proteinaceous compounds will also appreciate the material presented. These include food scientists, microbiologists, food processors and product physiologists, food toxicologists, and food and personal product regulators.

Front Cover 1
Bacteriocins of Lactic Acid Bacteria 4
Copyright Page 5
Table of Contents 8
Dedication 6
Contributors 16
Foreword 18
Preface 20
CHAPTER 1. 
22 
I. Introduction 22
II. Colicins 28
III. Killer Toxins, Yeast Antimicrobial 
31 
IV. Thionins, Plant Antimicrobial Proteins 32
V. Defensins, Animal Antimicrobial Proteins 35
VI. Conclusions 37
Acknowledgments 37
References 38
CHAPTER 2. Screening Methods for 
44 
I. Historical Perspective 44
II. Agar Diffusion Techniques 45
III. Liquid Media 56
IV. Titration of Bacteriocins: Critical 
57 
V. Survivor Counts 58
References 58
CHAPTER 3. Biochemical Methods for 
62 
I. Introduction 62
II. Detection and Assay of Bacteriocin 
63 
III. Production of Bacteriocins 63
IV. Bacteriocin Purification 69
V. Applications of Purified Bacteriocins 74
VI· Summary 77
References 78
CHAPTER 4. Applications and Interactions of Bacteriocins from Lactic Acid Bacteria in Foods 
84 
I. Introduction 84
II. Using Bacteriocinogenic Lactic Acid 
87 
III. Using Bacteriocinogenic Lactic Acid Bacteria and Bacteriocins to Direct Food 
91 
IV. Factors Affecting the Efficacy of 
97 
V. Assays for Bacteriocins in Foods 105
VI. Regulatory (United States) 
106 
Acknowledgments 107
References 107
CHAPTER 5. The Molecular 
114 
I. An Historical Perspective of Nisin 114
II. Significance of Posttranslationally 
116 
III. Lantibiotics Could be Adapted to 
118 
IV. A Dilemma Posed by Nisin Resistance 119
V. The Molecular Biology of Nisin 
121 
VI. Cloning of the Genes for the Nisin 
121 
VII. Evolutionary and Functional Relationships between Nisin and Subtilin Implied by Comparison of 
122 
VIII. Expression of the Genes for Nisin 
124 
IX. The Ability to Produce Subtilin Can Be 
126 
X. The Ability to Produce Nisin Can Be 
129 
XI. What is Known about the Organization 
130 
XII. What is Known about the Organization 
131 
XIII. Strategies and Systems to Express the 
133 
XIV. Processing of Chimeric 
135 
XV. Production of Natural and Engineered 
136 
XVI. Structural and Functional Analysis of Lantibiotic Analogues: The Dehydro Residues Provide a Window through Which the Chemical State of Nisin and 
137 
XVII. Conclusions and Future Prospects 139
Acknowledgments 140
References 140
CHAPTER 6. Nonnisin Bacteriocins in Lactococci: Biochemistry, 
142 
I. Summary 142
II. Introduction 143
III. Nomenclature 143
IV. Diplococcin 144
V. Lactostrepcins 146
VI. Lactococcins 148
VII. Conclusions and Future Prospects 165
Acknowledgments 167
References 167
CHAPTER 7. Molecular Biology of Bacteriocins Produced 
172 
I. Introduction 172
II. Evidence and Roles 173
III. Classification and Biochemical 
177 
IV. Genetic Organization of Bacteriocin Operons 181
V. Common Processing Sites 
194 
VI. Perspectives and Conclusions 196
Acknowledgments 198
References 198
CHAPTER 8. Pediocins 202
I. Introduction 202
II. Description of the Genus Pediococcus 202
III. Bacteriocin Activity in Pediococci 204
IV. Pediocin AcH 209
V. Additional Studies of Pediocins 
225 
VI. Other Potential Applications 
226 
Acknowledgments 227
References 227
CHAPTER 9. Bacteriocins from Carnobacterium 
232 
I. Description of the Genera Carnobacterium 
232 
II. Habitats and Sources of Carnobacterium 
233 
III. Bacteriocins Produced by Carnobacterium 
234 
IV. Chemical Characterization of Leuconostoc and 
236 
V. Potential for Application of Carnobacteriocins or 
237 
References 238
CHAPTER 10. Bacteriocins from Dairy Propionibacteria and Inducible Bacteriocins of 
240 
I. Bacteriocins from Dairy Propionibacteria 240
II. Inducible Bacteriocins of Lactic 
247 
Acknowledgment 249
References 249
CHAPTER 
254 
I. Introduction 254
II. Characteristics of Bacteriocins 255
III. Potential Uses of Bacteriocins or Bacteriocin-Producing Organisms 
256 
IV. Factors Affecting Regulatory Approval 
258 
V. Factors Affecting Regulatory Approval of Naturally Occurring 
260 
VI. Factors Affecting Regulatory Approval of Genetically Engineered 
261 
VII. Players in the Regulatory Arena 264
VIII. Future Challenges 266
IX. Conclusion 267
References 267
CHAPTER 12. Future Prospects for Research and Applications of Nisin and Other Bacteriocins 270
I. From Past to Present 270
II. Research Approaches and Incentives 272
III. Genetic Engineering 273
IV. Traditional and Molecular Screening 277
V. Protein Engineering 279
VI. Concluding Remarks 282
Acknowledgments 283
References 283
Index 288
FOOD SCIENCE AND TECHNOLOGY 298

CHAPTER 2

Screening Methods for Detecting Bacteriocin Activity


DALLAS G. HOOVER

SUSAN K. HARLANDER

Publisher Summary


This chapter discusses the screening methods for detecting bacteriocin activity. It also discusses the plating methods. The primary means for detecting bacteriocin activity of the lactic acid bacteria is the agar plate diffusion assay. Agar plate assays are popular for screening of antagonistic activity, monitoring expression, optimization, and inactivation of bacteriocins for their characterization. While these plating methods are straightforward, they are not without certain problems and limitations, as lactic acid bacteria can produce other antagonistic compounds and create conditions that mimic bacteriocin activity. Liquid methods are not as commonly used for the screening of bacteriocin activity. While plating methods are simpler and quicker to do, the use of liquid methods usually presents greater option for closer examination of bacteriocin activity. Assessment of the efficacy of a bacteriocin or bacteriocin-producing culture in a model food system is normally conducted by challenge with an indicator organism in the food and subsequent monitoring of the viability of the indicator using plate count methods.

I Historical Perspective


The demonstration of inhibitive effects between separate cultures of bacteria is well established. The earliest work includes a recorded observation by Antonie van Leeuwenhoek in 1676 that the product from one microorganism retarded the growth of another. Louis Pasteur, with J. F. Joubert in 1877, documented an antagonistic effect of bacteria from urine against Bacillus anthracis. As so often has been the case, such observations of antibiosis may not be elucidated to the point of determining the actual mechanism of action. Inhibition can be due to low molecular weight antibiotics, lytic agents, enzymes, defective bacteriophage, and other metabolic by-products such as ammonia, organic acids, free fatty acids, carbon dioxide, and hydrogen peroxide. In addition, nutrient depletion and lowering of the redox potential of the medium may antagonize growth of competing strains to some extent. Given the diversity of naturally occurring antagonistic compounds, it is often a challenge to quantify bacteriocin activity while eliminating or measuring other inhibitive effects, some of which may be synergistic with the activity of bacteriocins. Such factors in lactic acid bacteria have been earlier summarized by Klaenhammer (1988).

Total agreement does not exist for the definition of bacteriocin. For this chapter the broader and simpler description will be used, and that is, a bacteriocin is a peptide or protein produced by a bacterium that inhibits the growth of another bacterium.

In spite of numerous inhibitive factors, bacteriocins are ubiquitous in nature. As noted in the milestone review of bacteriocins from Gram-positive bacteria (Tagg et al., 1976), screening of a relatively large number of strains (100 or more) of any one bacterial species will usually offer some evidence of inhibition due to a bacteriocin. Tagg et al. (1976) exemplified this wide occurrence by summarizing 57 papers that surveyed different species of Gram-positive bacteria for strains that produced a bacteriocinlike effect. In eight studies that surveyed the production of bacteriocin activity from cultures of Staphylococcus aureus, the occurrence of bacteriocin activity ranged from 1 to 38% of the strains examined with an average of about 13%. The number of strains of staphylococci evaluated in these studies was from 65 to 2035. Five studies that screened for the presence of bacteriocin activity in group D streptococci found a range of 51 to 99% for bacteriocin-positive strains with an overall frequency of occurrence of about 74%. The number examined ranged from 77 to 108 strains.

II Agar Diffusion Techniques


A Introduction


The first antimicrobial susceptibility test that utilized diffusion of the antibiotic substance through agar media was done by Fleming in 1924 with penicillin against Staphylococcus aureus. Cutting wells into the agar to serve as reservoirs for liquid preparations of antimicrobial agents has been a popular modification (Reddish, 1929). Another approach has been to use sensitivity disks (sterile paper containing diffusible antibiotic) whereby the relationship between diameters of the zones of inhibition in lawns of indicator-seeded agar determines the minimum inhibitory concentration (MIC). Such MIC values are normally derived from serial dilutions of the antibiotic (usually twofold).

There have been many adaptations of the agar zone diffusion technique since it was first used in the testing of antimicrobial compounds (Abraham et al., 1941). Common to these techniques is the measurement of the zones of inhibition in indicator-seeded agar plates (Figure 1). The antimicrobial agent diffuses through the agar to inhibit growth of the indicator organism. With the agar diffusion method, Vesterdal (Cooper, 1964) found the gradient or zone of inhibition to be established when the charge or concentration at the source is well defined and a gradient is established by gradual exhaustion of the diffusing antibiotic (x or r;x = rrd). There is a linear relationship between the response and the log10 dose. The zone size is a result of diffusion of the antimicrobial compound and the growth rate of the indicator organism (Linton, 1983). An antibiotic compound will diffuse through an agar at a constant rate depending upon its molecular weight, its ionic charge, and the composition of the gel. Temperature and solvent viscosity of the gel will affect this constant. Most microbiological assays are conducted isothermally, but should two different incubation temperatures be used to either prediffuse the antibiotic or to allow optimum growth temperatures to be used for the producing and indicator strains of a deferred antagonism assay, then the diffusion rate will change and the slope of an assay curve will be altered (Figure 2).


Figure 1 A zone of inhibition formed by radial diffusion in solidified medium.

Figure 2 The influence of inoculum size on zones of inhibition. The test organism is Klebsiella pneumoniae with three concentrations of streptomycin (1000, 100, and 10 μg/ml: A, B, and C, respectively). The test was carried out at 35°C. The denser the inoculum, the smaller the zone sizes until, with an inoculum of log2 = 26 and greater, no zones were produced. (From Linton, 1958.)

The amount of antibiotic compound will directly affect the zone of inhibition; the greater the concentration, the greater the zone diameter under standard conditions (Figure 2). The higher the amount of antibiotic substance present, the farther it diffuses out into the agar in a given time period. When there is a significant difference between the critical concentration of the antibiotic that inhibits the indicator organism under conditions of diffusion and the antibiotic concentration at the source (which is usually considered constant) the zone edge tends to be crisp. When they are similar, the zone edges may appear nondescript or diffuse (Linton, 1983).

Overnight incubation is the usual minimum length of time until measurement of zones of inhibition, but the actual location of the zone edge is fixed within a few hours of incubation, after which time the indicator organism grows outside the zone and becomes visible. This length of time for growth is determined by the type of microorganism tested for sensitivity, the nutritional status of the growth medium, the incubation temperature, and the inoculum size (Linton, 1983). Generally, the greater the inoculum, the shorter the required growth time; but too dense an inoculum results in no zones of inhibition because the initial high cell number will mask any subsequent zone formation (Figure 2). Large zones of inhibition are usually formed when the bacteria are slow growing (e.g., due to adverse temperature or minimal media), and small zones are usually formed when bacteria grow rapidly (Piddock, 1990).

In those systems in which the diffusion of the antibiotic and the growth of the indicator organism are simultaneous, all sensitive organisms within the forming zone of inhibition are initially inhibited by the critical inhibitory concentration of the antibiotic diffusing from the source. As incubation continues, cells beyond the zone grow to greater density. At the zone edge, an inhibitory concentration of antibiotic interacts with a cell density that is large enough to absorb antibiotic to an extent large enough to significantly lower the concentration of antibiotic to one that is no longer inhibitory. As the indicator grows in the log phase, the diffusing antibiotic is maintained at a subinhibitory level by the increased density of the indicator organism, and therefore the organism grows uninhibited and becomes visible.

Most antibiotics appear to be diffusible through agar gels, although in some cases this may occur slowly. In those assays in which prediffusion of the antibiotic compound is desirable because the agent diffuses slowly, (e.g., because of large molecular weight or polymeric forms), the initiation of indicator organism...

Erscheint lt. Verlag 28.6.2014
Sprache englisch
Themenwelt Naturwissenschaften Biologie
Technik
ISBN-10 1-4832-7367-9 / 1483273679
ISBN-13 978-1-4832-7367-9 / 9781483273679
Haben Sie eine Frage zum Produkt?
PDFPDF (Adobe DRM)
Größe: 21,9 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

EPUBEPUB (Adobe DRM)
Größe: 7,3 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich